时间:2024-09-20 09:10:12 来源:网络整理编辑:休閑
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a patient’s physician or caregiver when it’s been ingested, the agency announced on Monday.
The Japanese drug maker Otsuka Pharmaceutical won the approval for an upgraded version of Abilify, the antipsychotic drug first approved 15 years ago to treat schizophrenia, bipolar disorder, and depression. Otsuka collaborated with Proteus Digital Health, the Silicon Valley company that designed the futuristic sensor technology.
SEE ALSO:Big Pharma’s big push to get patients to take their medsThe new product, which will be sold as Abilify MyCite, can be swallowed just like any other pill. When that happens, the ingestible sensor inside it sends a message to a patch worn by the patient, which then transmits the information to a mobile app that the patient can monitor. If a patient opts to allow it, the patient’s caregivers and doctor can access the data online, too.
The FDA’s decision Monday comes a year and a half after the agency rejected the product. At the time, the agency said it needed more information about how the product is used and how human error could create risks. Monday’s hard-won approval could come as a big boost for Otsuka, which had lost market share after Abilify went generic but will now have a way to make the product stand out.
Forgetfulness and cloudy thinking can be symptoms of the mental health conditions that Abilify is approved to treat, and patients with mental illness are known to struggle to take medication consistently. But the new product will also be labeled with a caveat: There’s no evidence that the technology can help patients take their medication as prescribed.
The landmark approval is the latest in an expansive rethinking of what constitutes a treatment. In September, the FDA approved the first mobile app to treat certain substance use disorders, developed by the Boston company Pear Therapeutics.
TopicsHealth
Xiaomi accused of copying again, this time by Jawbone2024-09-20 08:57
李昂有望加盟海港 江蘇“停運”如何界定成關鍵2024-09-20 08:37
遼寧沈陽隊主帥:中甲無直接降級壓力 將放棄外援引進2024-09-20 08:34
哀悼!前甲A外援門將心髒驟停去世 曾效力沈陽海獅2024-09-20 08:25
Mom discovers security cameras hacked, kids' bedroom livestreamed2024-09-20 07:56
國足40強賽或提前至5月31日開打 足協正與亞足聯溝通2024-09-20 07:45
曝吳曦將加盟上海海港 恒大國安魯能恐“白忙一場”2024-09-20 07:35
尤文歐冠前瞻:C羅欲再主導逆轉好戲 眾傷員複出2024-09-20 07:25
Daughter gives her 1002024-09-20 06:52
多特四年來首次進八強 過去兩年均輸給歐冠亞軍2024-09-20 06:51
Katy Perry talks 'Rise,' her next batch of songs, and how to survive Twitter2024-09-20 08:54
C羅遭遇名宿炮轟!尤文高層:球隊沒與他談續約2024-09-20 08:49
足協放寬引援名額限製 3隊麵臨解散球員仍難找下家2024-09-20 08:46
儒尼奧爾:亞泰是有潛力的球隊 團隊成績在個人榮譽之上2024-09-20 08:28
Katy Perry talks 'Rise,' her next batch of songs, and how to survive Twitter2024-09-20 08:24
C羅遭遇名宿炮轟 !尤文高層:球隊沒與他談續約2024-09-20 08:21
滬媒 :李昂選擇上海非常明智 需等待江蘇隊退出後官宣2024-09-20 07:53
記者談吳曦轉會:被提及最多的球隊 不見得是最接近的2024-09-20 07:28
Man stumbles upon his phone background in real life2024-09-20 07:19
曼聯雙倍周薪續約B費遭球員拒絕 被要求先展示雄心2024-09-20 07:12